Latest News and Press Releases

STOCKHOLM, Sweden, March 29, 2004 (PRIMEZONE) -- Artimplant, a biomaterials and orthobiologics company based in Gothenburg, Sweden, has received new CE certificates with extended indications for two...

STOCKHOLM, Sweden, Feb. 23, 2004 (PRIMEZONE) -- Patients with chronic injuries to the ulnar collateral ligament (UCL) in the first metacarpophalangeal joint (thumb ligament) show that the initially...

STOCKHOLM, Sweden, Jan. 27, 2004 (PRIMEZONE) -- Patients with a high level of physical activity that perform accelerated rehabilitation after having been operated with Artimplant's Artelon(TM)...

STOCKHOLM, Sweden, Jan. 15, 2004 (PRIMEZONE) -- Artimplant AB, a Swedish biomaterials company, has been granted CE- certification for its Artelon(TM) Surgical Suture, i.e. approval to market the...

STOCKHOLM, Sweden, Nov. 28, 2003 (PRIMEZONE) -- The Extraordinary Shareholder's Meeting in Artimplant on November 28, 2003, decided to approve of the Board of Director's decision on November 6, 2003...

STOCKHOLM, Sweden, Nov. 18, 2003 (PRIMEZONE) -- Artimplant has its first product cleared by FDA. The company's Artelon(TM) Surgical Suture has been approved for marketing in the US. The decision was...

STOCKHOLM, Sweden, Nov. 7, 2003 (PRIMEZONE) -- In the past 12-month period Artimplant has successfully implemented an extensive action plan and reached several important mile stones: -- Product...

STOCKHOLM, Sweden, Nov. 07, 2003 (PRIMEZONE) -- Artimplant: ARTIMPLANT DIVESTS GOTHENBURG MEDICAL CENTER -- Consolidated net sales January-September 2003 reached SEK 20,3 million (SEK...

STOCKHOLM, Sweden, Sept. 30, 2003 (PRIMEZONE) -- Artimplant (Other OTC:APLTF) has entered a contractual agreement to divest the Gothenburg Medical Center (GMC) to a group of private...

STOCKHOLM, Sweden, Aug. 29, 2003 (PRIMEZONE) -- Artimplant (Other OTC:APLTF) - Consolidated net sales January-June 2003 reached SEK 14,7 million (SEK 13,1 million) - The loss after taxes was SEK...